Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

FDA Panelists Questioned Antidepressants in Pregnancy. But Doctors Call Them a Lifeline.

FDA panel raised safety concerns about SSRIs during pregnancy, while experts warn this could increase untreated maternal depression affecting 20% of U.S. women, CDC data shows.

Summary by News Medical
Open the article to view the coverage from News Medical

8 Articles

kffhealthnews.orgkffhealthnews.org
+6 Reposted by 6 other sources
Center

FDA Panelists Questioned Antidepressants in Pregnancy. But Doctors Call Them a Lifeline.

Open the article to view the coverage from kffhealthnews.org

Read Full Article
USA TodayUSA Today
Lean Left

These moms are thankful for SSRIs during pregnancy. Now the drugs are an FDA flashpoint.

Medical experts are concerned that a panel discussion convened by the Food and Drug Administration could lead to more cases of untreated depression.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources are Center
60% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

USA Today broke the news in United States on Sunday, December 14, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Mental Health icon

Mental Health

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal